NCT00818545View on ClinicalTrials.gov

Transcriptomic Study of ER 4017 Topical Application in Elderly Subject

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Aging
Interventions
DRUG

ER4017 (hydroxypropyltetrahydropyrantriol)

Cream, 10%, each day during 3 months

DRUG

placebo

Trial Locations (1)

75010

Centre de recherche bioclinique -Hopital st louis, Paris

All Listed Sponsors
lead

L'Oreal

INDUSTRY

NCT00818545 - Transcriptomic Study of ER 4017 Topical Application in Elderly Subject | Biotech Hunter | Biotech Hunter